Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.

ABSTRACT:

Background

Psychedelics are receiving growing interest among clinical researchers for their effects on mood and cognition. Psilocybin is one of the most widely studied classic psychedelics which has shown good safety and clinical benefit for major depression and substance use disorders. Athletes frequently sustain concussions and often experience myriad symptoms, including cognitive and mood issues, which can persist for weeks or months in 10%-30% of athletes. Psilocybin may be a potential symptom management option for athletes with persisting concussion symptoms.

Objectives

This study sought to summarize athlete psychedelic use, among other substances, and to examine the willingness of the sports community to engage in or support psilocybin-assisted therapy (PAT) for concus

SUBMITTER: VanderZwaag B 

PROVIDER: S-EPMC11311162 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature